These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25533129)

  • 1. Platelet-lymphocyte ratio is a predictor of venous thromboembolism in cancer patients.
    Yang W; Liu Y
    Thromb Res; 2015 Aug; 136(2):212-5. PubMed ID: 25533129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
    Ferroni P; Riondino S; Formica V; Cereda V; Tosetto L; La Farina F; Valente MG; Vergati M; Guadagni F; Roselli M
    Int J Cancer; 2015 Mar; 136(5):1234-40. PubMed ID: 25042739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
    Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
    J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer.
    Go SI; Lee A; Lee US; Choi HJ; Kang MH; Kang JH; Jeon KN; Park MJ; Kim SH; Lee GW
    Lung Cancer; 2014 Apr; 84(1):79-85. PubMed ID: 24524817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of platelet activation markers with cancer-associated venous thromboembolism.
    Riedl J; Hell L; Kaider A; Koder S; Marosi C; Zielinski C; Panzer S; Pabinger I; Ay C
    Platelets; 2016; 27(1):80-5. PubMed ID: 25970326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous Thromboembolism Risk in Head and Neck Cancer: Significance of the Preoperative Platelet-to-Lymphocyte Ratio.
    Tham T; Rahman L; Persaud C; Olson C; Costantino P
    Otolaryngol Head Neck Surg; 2018 Jul; 159(1):85-91. PubMed ID: 29406795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).
    Simanek R; Vormittag R; Ay C; Alguel G; Dunkler D; Schwarzinger I; Steger G; Jaeger U; Zielinski C; Pabinger I
    J Thromb Haemost; 2010 Jan; 8(1):114-20. PubMed ID: 19889150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients.
    Piran S; Ngo V; McDiarmid S; Le Gal G; Petrcich W; Carrier M
    Thromb Res; 2014 Jan; 133(1):30-3. PubMed ID: 24188799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Current Thromboembolism Risk Assessment Tools in Patients With Gastric Cancer and Validity After First Treatment.
    Fuentes HE; Paz LH; Wang Y; Oramas DM; Simons CR; Tafur AJ
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):790-796. PubMed ID: 28884610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Risk Factors for Venous Thrombosis.
    Artoni A; Abbattista M; Bucciarelli P; Gianniello F; Scalambrino E; Pappalardo E; Peyvandi F; Martinelli I
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):808-814. PubMed ID: 29088921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Di Micco P; Iannuzzo M; Lecumberri R; Guijarro R; Madridano O; Monreal M;
    Thromb Haemost; 2008 Nov; 100(5):905-11. PubMed ID: 18989537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.
    Kuderer NM; Culakova E; Lyman GH; Francis C; Falanga A; Khorana AA
    Oncologist; 2016 Jul; 21(7):861-7. PubMed ID: 27125754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of chemotherapy-associated venous thromboembolism in elderly patients with cancer.
    Vergati M; Della-Morte D; Ferroni P; Cereda V; Tosetto L; La Farina F; Guadagni F; Roselli M
    Rejuvenation Res; 2013 Jun; 16(3):224-31. PubMed ID: 23521603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients.
    Ay C; Pabinger I
    Thromb Res; 2012 Apr; 129 Suppl 1():S6-9. PubMed ID: 22682135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism after major cancer surgery: temporal trends and patterns of care.
    Trinh VQ; Karakiewicz PI; Sammon J; Sun M; Sukumar S; Gervais MK; Shariat SF; Tian Z; Kim SP; Kowalczyk KJ; Hu JC; Menon M; Trinh QD
    JAMA Surg; 2014 Jan; 149(1):43-9. PubMed ID: 24197279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS).
    Riedl J; Kaider A; Reitter EM; Marosi C; Jäger U; Schwarzinger I; Zielinski C; Pabinger I; Ay C
    Thromb Haemost; 2014 Apr; 111(4):670-8. PubMed ID: 24306221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients.
    Königsbrügge O; Posch F; Riedl J; Reitter EM; Zielinski C; Pabinger I; Ay C
    Oncologist; 2016 Feb; 21(2):252-7. PubMed ID: 26764252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS).
    Königsbrügge O; Pabinger I; Ay C
    Thromb Res; 2014 May; 133 Suppl 2():S39-43. PubMed ID: 24862144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy.
    Langsenlehner T; Pichler M; Thurner EM; Krenn-Pilko S; Stojakovic T; Gerger A; Langsenlehner U
    Urol Oncol; 2015 May; 33(5):201.e9-16. PubMed ID: 25769845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.